Search

Your search keyword '"Mikhailidis, Dimitri P."' showing total 16 results
Start Over Author "Mikhailidis, Dimitri P." Publication Type Books
16 results on '"Mikhailidis, Dimitri P."'

13. Cardiovascular Risk Factors and Peripheral Arterial Disease.

Author

Daskalopoulou, Stella S. and Mikhailidis, Dimitri P.

Abstract

A 62-year-old man with intermittent claudication was referred for vascular risk factor modification. He had no history of myocardial infarction (MI) or stroke. He was smoking 20 cigarettes/day. His family history was negative for premature vascular events. He was not taking any medication. He was advised to start aspirin 75 mg/day, but he stopped taking these tablets because of ˵stomach discomfort″. The patient΄s total cholesterol was 228 mg/dL (5.9 mmol/L). His blood pressure required treatment with amlodipine and a thiazide diuretic. The patient eventually stopped smoking after referral to the smoking cessation clinic in our hospital. [ABSTRACT FROM AUTHOR]

Published
2011
Full Text
View/download PDF

14. Peripheral Arterial Disease and Emerging Biochemical Vascular Risk Factors.

Author

Arnold, Wolfgang, Ganzer, Uwe, Balzer, Klaus, Benedetti-Valentini, Fabrizio, Fernandes e Fernandes, José, Daskalopoulou, Stella S., Daskalopoulos, Marios E., Liapis, Christos D., and Mikhailidis, Dimitri P.

Abstract

Peripheral arterial disease (PAD) affects more than 10 million people in the United States. The risk factors as- sociated with PAD are similar to those for coronary heart disease (CHD) and cerebrovascular disease (CVD )[4,7]. Medical therapy of PAD must include modification of vascular risk factors with application of strict secondary prevention guidelines [7]. [ABSTRACT FROM AUTHOR]

Published
2007
Full Text
View/download PDF

15. Lipids and Peripheral Arterial Disease.

Author

Arnold, Wolfgang, Ganzer, Uwe, Balzer, Klaus, Benedetti-Valentini, Fabrizio, Fernandes e Fernandes, José, Daskalopoulou, Stella S., Daskalopoulos, Marios E., Liapis, Christos D., and Mikhailidis, Dimitri P.

Abstract

Peripheral arterial disease (PAD) is associated with a high risk of vascular events [1, 2, 14, 18, 19, 31, 32]. This is true whether PAD is symptomatic or asymptomatic.This risk is so high that PAD is considered as a coronary heart disease (CHD) equivalent [5, 13]. It follows that these patients need to have their modifiable vascular risk fac- tors controlled. Dyslipidaemia, a modifiable vascular risk factor, should be treated aggressively with lipid-lowering drugs, according to international guidelines [5, 13, 16, 37]. The earlier low density lipoprotein-cholesterol (LDL-C) targets {European LDL-C target <96 mg/dl (2.5 mmol/l) [ABSTRACT FROM AUTHOR]

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results